Pharmasset, Inc. - Investor Relations

www.Pharmasset.com

August 07, 2008 03:31 PM

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Search Investor Relations

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Pharmasset, Inc. 's financial performance into perspective.

Stock Quote

NASDAQ : VRUS
$21.93

1.37

As of Aug 7, 2008 at 3:16 PM ET

Quotes delayed at least 20 minutes. Information provided by TurboFeed.

Recent Releases

Aug 5, 2008
Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C

Jul 22, 2008
Pharmasset Announces Consummation of $24.18 Million Registered Direct Offering of Common Stock

View all releases »

Investor Relations Contact

Kurt Leutzinger
Chief Financial Officer
Office: +1 (609) 613-4110
Email

Site Design by Lakeshore Concepts